Showing 8661-8670 of 9871 results for "".
- Registration Open for Dermatology Nurses' Associaion's 32nd Annual Conventionhttps://practicaldermatology.com/news/20140221-registration_open_for_dermatology_nurses_associaions_32nd_annual_convention/2459335/The Dermatology Nurses' Association's 32nd Annual Convention will be held Thursday, May 1, 2014 through Sunday, May 4, 2014 at the Walt Disney World Swan and Dolphin Hotel, in Orlando, FL. Online registration is
- Topix Pharmaceuticals Introduces Replenix Restorative Nighttime Bio-Therapyhttps://practicaldermatology.com/news/20140213-topix_pharmaceuticals_introduces_replenix_restorative_nighttime_bio-therapy/2459344/Topix Pharmaceuticals, Inc., launched its Replenix Restorative Nighttime Bio-Therapy cream, a moisture-boosting, rich night cream formulated to attract, hold, and distribute moisture through a system of ceramides, humectants, and em
- Revance Therapeutics Announces Pricing of Initial Public Offeringhttps://practicaldermatology.com/news/20140207-revance_therapeutics_announces_pricing_of_initial_public_offering/2459346/Revance Therapeutics, Inc., a specialty biopharmaceutical company developing botulinum toxin products for use in aesthetic and therapeutic indications, announced the pricing of its initial public offering of 6,000,000 shares of its common stock at a public offering price of $16.00 per share, befo
- Valeant Pharmaceuticals Announces FDA Approval of Retin-A Micro Microsphere 0.08%https://practicaldermatology.com/news/20140131-valeant_pharmaceuticals_announces_fda_approval_of_retin-a_micro_microsphere_008/2459353/The FDA approved Valeant Pharmaceuticals' Supplemental New Drug Application (sNDA) for Retin-A Micro (tretinoin) Gel microsphere 0.08% for the topical treatment of acne vulgaris. "We are very pleased that the FDA ha
- Curt Cole Wins "Best Presentation of the Day" and Lifetime Achievement Awards at Winter Clinical Dermatology Conferencehttps://practicaldermatology.com/news/20140128-curt_cole_wins_best_presentation_of_the_day_and_lifetime_achievement_awards_at_winter_clinical_dermatology_conference/2459357/"Beyond Broad Spectrum: Critical Concepts in a Post-Monograph World " - a podium presentation by photobiologist and industry veteran Curtis Cole, Ph.D, - was voted "Best Presentation of the Day," Tuesday, January 21 at the Winter Clinical Dermatology Conference. Given the broad scope of topics
- AAD Responds to New York Timeshttps://practicaldermatology.com/news/20140127-aad_sumbits_letter_to_the_editor_to_new_york_times/2459358/In response to The New York Times article “Patients' Costs Skyrocket; Specialists' Incomes Soar” (“Paying Till It Hurts” series, Jan. 19, 2014), the American Academy of De
- DermatologistOnCall Launches Online Platformhttps://practicaldermatology.com/news/20140123-dermatologistoncall_launches_online_platform/2459362/DermatologistOnCall® has launched its online platform, allowing dermatologists to efficiently diagnose and prescribe a treatment plan for patients with more routine conditions via an online portal, while reserving in-office appointments for more severe cases. After a patient registers, dermatologist
- Everett Laboratories Acquires Quinnova Pharmaceuticalshttps://practicaldermatology.com/news/20140123-everett_laboratories_acquires_quinnova_pharmaceuticals/2459363/Everett Laboratories, Inc., a privately held specialty pharmaceutical company and a subsidiary of Exeltis, headquartered in
- Practical Dermatology® Magazine Names Neal Bhatia, MD, FAAD Co-Chief Medical Editorhttps://practicaldermatology.com/news/20140117-practical_dermatology_magazine_names_neal_bhatia_md_faad_co-chief_medical_editor/2459367/Neal Bhatia, MD, FAAD, San Diego-based dermatologist and well known lecturer and author, has been named Co-Chief Medical Editor of Practical Dermatology® magazine from Bryn Mawr Communications III, LLC. Now in it's 11th year of publicat
- Injectable Methotrexate Product Now Availablehttps://practicaldermatology.com/news/20140117-injectable_methotrexate_product_now_available/2459369/For patients who do not tolerate oral methotrexate for psoriasis, a new recently approved injectable methotrexate product is now available from Antares Pharma. Approved in October 2013 for the subcutaneous methotrexate product for once weekly self-administration, Otrexup is indicated for use in adul